Chukwuma Okoroji
Obstetrics & Gynecology · Tallahassee, FLNPI 1356335178
Payments from drug & device makers
Across 79 payments — averaging $112.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Sumitomo Pharma America, Inc.$195
- Roche Diagnostics Corporation$180
- AbbVie$127
- Hologic Sales And Service, LLC$117
- Daiichi Sankyo Inc.$116
- plus $597 from 16 others
What the payments were for
- Travel & lodging$5,06057%
- Food & beverage$1,44416%
- Education$2,00022%
- Gifts$3904%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 27 | $7,561 |
| Sumitomo Pharma America, Inc. | 5 | $195 |
| Roche Diagnostics Corporation | 10 | $180 |
| AbbVie | 5 | $127 |
| Hologic Sales And Service, LLC | 1 | $117 |
| Daiichi Sankyo Inc. | 5 | $116 |
| Astellas Pharma US Inc | 6 | $115 |
| AstraZeneca | 1 | $87 |
| Organon | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Bayer | 2 | $48 |
| Lupin Inc. | 2 | $43 |
| Sage Therapeutics, LLC | 1 | $33 |
| Pfizer | 1 | $31 |
| Apollo Endosurgery US Inc | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $19 |
| Duchesnay USA Incorporated | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Medicem Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
| Myovant Sciences Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,355
- DAVINCI XI$2,000
- Myosure$117
- NovaSure$117
- Omniscope$117
How this compares
$8,894 in reported general payments places this provider in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $30,008 |
| OzempicSemaglutide | 20 | $20,782 |
| FarxigaDapagliflozin Propanediol | 13 | $14,944 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,518 |
| ProgesteroneProgesterone, Micronized | 15 | $680 |
| ValacyclovirValacyclovir Hcl | 11 | $620 |
| Atorvastatin Calcium | 49 | $511 |
| Gabapentin | 29 | $488 |
| Amlodipine Besylate | 70 | $478 |
| Estradiol | 43 | $373 |
| Benazepril Hcl | 12 | $321 |
| Lisinopril | 36 | $296 |
| Ibuprofen | 26 | $282 |
| Omeprazole | 23 | $269 |
| Metformin Hcl | 59 | $243 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $87 | $14,94413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Tallahassee
- Samuel LedermanLake Worth$13.4M
- Richard MyersJacksonville$2.7M
- Guillermo LievanoMiami$2.5M
- Steven McCarusCelebration$2.3M
- Samuel WolfPanama City$2.1M
- Rafael Garcia-OcasioHialeah$2M
- Douglas MoffettLeesburg$1.7M
- Harvey GlasserAventura$1.6M
- Jorge PandoMiami Lakes$1.5M
- Victoria BedellMiami$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.